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Abstract
Background: Patients with major depressive disorder (MDD) present heterogeneous clinical symptoms, and childhood
abuse is associated with deepening of psychopathology. The aim of this study was to identify structural brain
abnormalities in MDD and to assess further differences in gray matter density (GMD) associated with childhood abuse
in MDD.
Methods: Differences in regional GMD between 34 MDD patients and 26 healthy controls were assessed using
magnetic resonance imaging and optimized voxel-based morphometry. Within the MDD group, further comparisons
were performed focusing on the experience of maltreatment during childhood (23 MDD with child abuse vs 11 MDD
without child abuse).
Results: Compared with healthy controls, the MDD patient group showed decreased GMD in the bilateral orbitofrontal
cortices, right superior frontal gyrus, right posterior cingulate gyrus, bilateral middle occipital gyri, and left cuneus. In
addition, the patient group showed increased GMD in bilateral postcentral gyri, parieto-occipital cortices, putamina,
thalami, and hippocampi, and left cerebellar declive and tuber of vermis. Within the MDD patient group, the subgroup
with abuse showed a tendency of decreased GMD in right orbitofrontal cortex, but showed increased GMD in the left
postcentral gyrus compared to the subgroup without abuse.
Conclusions: Our findings suggest a complicated dysfunction of networks between cortical-subcortical circuits in MDD.
In addition, increased GMD in postcentral gyrus and a possible reduction of GMD in the orbitofrontal cortex of MDD
patients with abuse subgroup may be associated with abnormalities of body perception and emotional dysregulation.
Keywords: Major depressive disorder, Physical abuse, Emotional abuse, Voxel-based morphometry, Orbitofrontal cortex,
Emotional dysregulation
Background
Although major depressive disorder (MDD) is one of the
leading causes of disease burden all around the world,
the etiology and pathophysiology remain uncertain [1].
Advanced magnetic resonance imaging (MRI) has been
used to identify the key brain regions involved in MDD.
Based on this work, several brain networks were suggested
to be associated with pathophysiology of MDD. First,
dysfunction in limbic-cortical circuitry, including the
orbitofrontal cortex (OFC), dorsolateral prefrontal cortex
(DLPFC), insular and temporal pole may be associated with
MDD [2–4]. Second, network dysfunction between dorsal
(dorsomedial prefrontal cortex, DLPFC, dorsal anterior
cingulate cortex (ACC), posterior cingulate cortex), and
ventral (subgenual anterior cingulate, amygdala) compo-
nents, as well as the rostral ACC, which connects the two
components, is suggested in the pathophysiology of MDD
[5, 6]. Third, cortico-subcortical circuitry including the
limbic-cortical-striatal-pallidal-thalamic circuit and also the
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medial and orbitofrontal cortex and their extended cortical
circuits, may be associated with development of MDD
[2, 7]. In contrast to the large number of imaging studies
supporting the first two networks, there has been less evi-
dence supporting the cortico-subcortical circuitry.
People who have experienced child abuse or maltreat-
ment have an increased risk of MDD, and the impact of
these experiences may extend throughout a person’s life-
time [8–11]. The emotional dysregulation may be a central
risk pathway to MDD following child abuse [12]. Bradley et
al., showed that child abuse altered the endogenous stress
response, principally corticotropin-releasing hormone [13].
Child abuse exhibited increased amygdala connectivity with
hippocampus and prefrontal cortex, implying alteration to
frontolimbic circuitry, one of circuitry in MDD [14].
However, it is still uncertain how child abuse affects
brain networks in the pathophysiology of MDD.
Voxel-based morphometry (VBM) has become an
established research method with which to explore brain
structure differences, and to elucidate brain networks
involved in specific diseases [15]. Since previous neuro-
imaging studies investigating the pathophysiology of
MDD have reported network dysfunction between cortical
and subcortical structures [2, 7], we predicted that gray
matter abnormalities in cortico-subcortical circuitry would
be observed in individuals with MDD in this study. In
addition, we assessed the GM density (GMD) differences




Thirty-four patients with MDD and 26 healthy controls
were recruited from the Department of Psychiatry out-
patient clinic at Gangnam Severance Hospital. The two
groups were matched by age, gender, and education. All
participants were right-handed. Depending on exposure to
physical or emotional abuse in childhood, patients with
MDD were divided into two subsets (23 MDD patients with
child abuse and 11 MDD patients without child abuse).
All patients were interviewed with the Structured Clinical
Interview for DSM-IV. They met the MDD in DSM-IV
criteria. Patients were excluded if they had a history of
seizures, head trauma, dementia, intellectual impairment,
neurological disease or neurosurgery, substance abuse or
dependence, chronic medical conditions, history of learning
disabilities, psychotic symptoms, or cardiovascular dis-
ease. Healthy control subjects had no personal history
of psychiatric illness and also met the exclusion criteria
outlined above.
The study was approved by the institutional review
board (IRB) of Gangnam Severance Hospital, and all par-
ticipants gave written informed consent after a complete
description of the study was provided to them.
Assessment
Depressive symptom severity of the participants was
assessed using the Korean version of the Beck Depression
Inventory (BDI) [16]. Screening for child abuse was con-
ducted with a “yes” or “no” questionnaire asking about the
presence of traumatic physical or emotional abuse experi-
ence during childhood. Patients reporting “yes” answers to
both physical and emotional abuse experience were in-
cluded into abuse subgroup and patients reporting “no”
answers to both abuse screening questionnaire into non-
abuse subgroup. Patients reporting equivocal answers to
abuse screening questionnaire were excluded for further
evaluation. Detailed inquiry about child abuse or stressful
experiences in early-life was conducted using the Korean
Childhood Abuse Experience Questionnaire developed by
Oh [17]. This questionnaire has 44 items that inquire
about exposure to five categories of stressful early-life ex-
periences, including emotional abuse (five items), physical
abuse (nine items), neglect (ten items), and inter-parental
violence (ten items) from the Parent-child Conflict Tactics
Scale [18], and ten items regarding to sexual abuse from
another scale developed by Korean researchers [19].
MRI protocol
Patients were imaged with a 3.0T MR unit (Discovery
MR750; GE Healthcare, Milwaukee, WI). Three-
dimensional Spoiled Gradient Echo (3D-SPGR) sequences
(TR/TE = 8.29/3.28; thickness = 1, field of view = 220 × 220,
matrix = 256 × 256 [reconstructed to 512 × 512], flip
angle = 12, reconstructed voxel = 0.430 × 0.430 × 1 mm)
were used for structural image.
Image analysis
All the structural MRI post-processing was performed
by a single experienced observer, unaware of patients’
information. Regional volumetric measurements were
conducted on the 3D-SPGR images, using an optimized
VBM protocol and the statistical parametric mapping
(SPM 12) software [20].
The 3D MR datasets of all patients and controls were
processed using following steps: (1) custom template
creation: a study-specific whole brain T1-weighted
template and prior images of gray matter (GM), white
matter (WM), and cerebrospinal fluid (CSF) were cre-
ated based on the Montreal Neurological Institute
(MNI) template in SPM12. (2) Segmentation: each partici-
pant’s original image was spatially normalized based on
the customized template and subsequently segmented into
GM, WM, and CSF based on the customized priors. (3)
Smoothing: the normalized and segmented GM images
were re-sliced by 1.5 mm× 1.5 mm× 1.5 mm voxels and
smoothed using a Gaussian kernel of 8 mm full-width at
half-maximum.
Ahn et al. BMC Psychiatry  (2016) 16:397 Page 2 of 7
Statistical analysis
A two-sample t-test was performed using SPM12 to
compare the difference of GMD between MDD patients
and healthy controls while controlling for age, gender,
and total gray matter volume (TGMV) effects. Statistical
significances for group differences were set at threshold
of AlphaSim corrected p < 0.05, which corresponds to an
uncorrected p < 0.001 and cluster size k >128 voxels. The
extent of cluster size was estimated through a MonteCarlo
simulation using AFNI’s AlphaSim program [21] with
10,000 iterations. Additionally, within the MDD group,
further comparison focusing on the experience of child-
hood abuse was conducted using SPSS 20.0 software
(IBM Corp. Released 2011. IBM SPSS Statistics for
Windows, Version 20.0. Armonk, NY: IBM Corp.). The
confounding effects from age, gender, TGMV, and BDI
score were controlled in comparisons of MDD patients
with and without childhood abuse. A p-value less than
0.05 was considered statistically significant.
Results
Clinical characteristics
There were no significant differences in demographic
characteristics such as age, gender, education year between
the subjects in this study. Depression severity score was sig-
nificantly higher in the MDD patient group than in the
healthy control group. As shown in Table 1, MDD patients
with abuse subgroup reported more stressful experiences in
their early life compared to individuals in the other two
groups (i.e., MDD without abuse or healthy controls).
Voxel-based morphometry
Compared with healthy controls, the MDD patient group
showed decreased GMD in the bilateral orbitofrontal cor-
tices, right superior frontal gyrus, right posterior cingulate
gyrus, bilateral middle occipital gyri, and left cuneus. This
group also showed increased GMD in the bilateral post-
central gyri, parieto-occipital cortices, putamina, thalami,
and hippocampi, and left cerebellar declive and tuber of
vermis (Table 2 and Fig. 1).
Within the MDD patient group, the MDD with abuse
subgroup showed increased GMD in the left postcentral
gyrus, and a tendency of decreased GMD in the right
orbitofrontal cortex compared to the MDD without
abuse subgroup (Additional file 1 and Fig. 2). There was
no significant correlation between GMD and abuse ex-
perience scores within MDD patient group.
Discussion
In this study, we demonstrated that individuals with
MDD showed decreased GMD in cortical regions in-
cluding the OFC, right dorsomedial prefrontal cortex
(DMPFC) and posterior cingulate cortex, but showed in-
creased GMD in the subcortical regions including puta-
men and thalamus compared to healthy controls. In
addition, individuals with MDD who also experienced
child abuse showed increased GMD in the left postcen-
tral gyrus and a possibility of decreased GMD in the
right orbitofrontal cortex.
Our findings suggest that MDD may be associated
with structural abnormalities in fronto-striato-thalamic
Table 1 Clinical characteristics of the participants
MDD CONT Post hoc**
MDD with abusea (N = 23) MDD without abuseb (N = 11) Healthy controlsc (N = 26) p* Comparison (p)
Male/Female 3/20 2/9 7/19 0.484
Age (years) 32.3 ± 7.4 32.7 ± 8.5 31.4 ± 7.6 0.866
Education (years) 14.8 ± 2.1 16.0 ± 2.3 16.0 ± 1.6 0.090
Beck depression inventory score 32.3 ± 11.8 27.6 ± 5.2 3.0 ± 3.4 <0.001 a>c <0.001
b>c <0.001
Early-life stress factor score
Emotional abuse 12.3 ± 4.6 1.7 ± 1.6 1.9 ± 2.0 <0.001 a>b <0.001
a>c <0.001
Physical abuse 7.4 ± 5.6 0.9 ± 0.9 1.3 ± 0.9 <0.001 a>b <0.001
a>c <0.001
Sexual abuse 0.7 ± 1.0 0.2 ± 0.4 0.05 ± 0.1 0.003 a>c 0.002
Neglect 3.1 ± 3.9 0.2 ± 0.5 0.2 ± 0.6 <0.001 a>b 0.008
a>c <0.001




Note: CONT control group, MDD major depressive disorder patient group
*Fisher’s exact test for gender variable was done; Analyses of variance test for continuous variable were done
**post-hoc test with Bonferroni’s method (a: MDD with abuse, b: MDD without abuse, c: healthy controls)
p-value less than 0.05 was considered significant
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regions, supporting for a cortico-subcortical network
dysfunction in the development of MDD [2, 7]. In
addition, early-life stressful experiences such as physical
or emotional abuse may have an additional impact on
brain structure associated with body perception and
emotion regulation in MDD patients [22].
Our findings regarding decreased GMD of the bilateral
OFC, right DMPFC, and dorsal anterior cingulate cortex
are consistent with several prior studies. OFC lesions are
known to be associated with a wide range of abnormal
affective behaviors including affective instability, irritability,
aggression, and depression- or anxiety- related symptoms,
which are frequently observed in MDD patients [23, 24]. A
postmortem study found significant decreases in cortical
thickness of the OFC in MDD patients compared with
healthy controls [25]. Several MRI-based studies reported
bilateral reduction of OFC volumes in depressed patients
[26, 27]. Abnormally increased OFC metabolism or regional
cerebral blood flow have been observed in MDD patients
[28]. DMPFC lesions also conferred an increased risk of se-
vere depression, compared to lesions outside the prefrontal
cortex [29]. A recent meta-analysis of VBM studies showed
only minimal GMD changes in the DLPFC, but extensive
abnormalities in the DMPFC and adjacent anterior cingu-
late cortex [30]. Moreover, the DMPFC was identified as a
Table 2 Regions of significantly different GMD in MDD patients compared to healthy controls
Anatomical Region Side BA MNI coordinate, mm Number of voxel Zscore
x y z
Increased gray matter density in MDD
Postcentral gyrus L 4 −39 −27 52 210 3.99
Postcentral gyrus R 4 36 −24 54 518 5.05
Parieto-occipital cortex L 31 −8 −70 26 140 3.45
Parieto-occipital cortex R 23 4 −64 18 166 3.91
Putamen L −26 4 −4 1219 4.90
Putamen R 26 8 −6 2174 5.05
Thalamus R 4 −27 2 3687 4.80
Hippocampus L −16 −36 −4 4.44
Hippocampus R 24 −33 −1 4.98
Cerebellum (Declive) L −20 −75 −20 175 3.46
Cerebellum (Tuber of vermis) R 3 −76 −26 621 4.19
Decreased gray matter density in MDD
Orbitofrontal cortex L −14 46 −18 139 4.08
Orbitofrontal cortex R 11 20 62 −20 224 3.93
Dorsomedial prefrontal cortex R 8 15 32 54 149 3.72
Dorsal anterior cingulate cortex R 24 6 −21 39 153 3.45
Middle occipital gyrus L −36 −87 22 292 4.16
Middle occipital gyrus R 18 38 −88 −8 497 4.71
Cuneus L 17 −8 −98 10 245 4.40
Note: L left hemisphere, R right hemisphere, BA Brodmann’s area; the threshold was set at AlphaSim corrected p < 0.05
Fig. 1 Statistical comparisons of GMD between MDD patients and
healthy controls (HC). Clusters colored with red (blue) indicate the
increased (decreased) GMD in MDD patients. Abbreviations: GMD,
gray matter density; MDD, major depressive disorder; HC, healthy
controls; CUN, cuneus; dmPFC, dorsomedial prefrontal cortex; L, left;
MOG, middle occipital gyrus; OFC, orbitofrontal cortex; PCC, posterior
cingulate cortex; POC, parieto-occipital cortex; PoCG, postcentral gyrus;
PUT, putamen; R, right; THL, thalamus
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‘dorsal nexus’ in depression where cortical network, affect
regulation, and self-reflections converge in depressed
patients [31]. Although still controversial, reduced volume
in the dorsal anterior cingulate cortex has been also re-
ported [32–34].
Evidence supporting the possible involvement of the
basal ganglia in the pathophysiology of MDD comes pri-
marily from clinical observations. Movement disorders
with known basal ganglia pathology such as Parkinson’s
disease have associated depressive and other psychiatric
symptoms, even before the onset of motor abnormalities
[35]. Postmortem studies have also supported an involve-
ment of the basal ganglia in the pathophysiology of MDD
[36]. There is a large amount of indirect evidence support-
ing the presence of extensive dopaminergic, noradrenergic,
and serotonergic projections to the basal ganglia, which
might constitute the most important neural pathways in
the pathophysiology of MDD [37–39]. Although a meta-
analysis of brain volume abnormalities in MDD demon-
strated moderate volume reductions for the caudate and
putamen in individuals with MDD compared to healthy
controls, another study reported no significant differences
in this region between groups [40–42]. Interestingly, unlike
previous results, our study showed increased GMD in the
basal ganglia. Basal ganglia are known to be involved in
direct and indirect pathway linking various cortical
regions to subcortical area. Considering reciprocal con-
nections between frontal and basal ganglia through the
cortico-thalamo-striatal circuit, frontal hypoactivity may
induce compensatory hyperactivity or increased volume of
the basal ganglia. Previous VBM studies in patients with
fibromyalgia, which frequently accompanies depressive
symptoms, showed increased basal ganglia volume com-
pared to healthy controls [43]. Clinical heterogeneity in
patients with MDD may contribute these equivocal find-
ings. Additional large-scale studies focusing on structural
and functional changes of the basal ganglia in MDD could
clarify equivocal findings in these regions.
Child abuse may have a deleterious long-term impact
on the developing brain [8]. Previous studies have re-
vealed that early-life trauma may protract cognitive
development, which can be regained after the traumatic
situation has ceased; but emotional dysfunction, which is
difficult to be recovered spontaneously after early-life
trauma has ceased, may increase risk for later psycho-
pathology [44]. MDD patients who have experienced
child abuse frequently have problems with regulation of
emotions; this is not easily treated with antidepressants
and these individuals show a higher prevalence of comorbid
borderline personality disorder [45]. In this study, we ob-
served further reduction of GMD in the right orbitofrontal
cortex of individuals in the MDD with child abuse
Fig. 2 GMD differences between MDD with child abuse, MDD without child abuse, and healthy controls. Clusters colored with red (blue) indicate
the increased (decreased) GMD in MDD patients, compared to heathy control. Cluster marked with red (blue) arrow indicate the increased
(decreased) GMD in MDD with child abuse, compared to MDD without child abuse. a left postcentral gyrus, b right orbitofrontal cortex.
Abbreviations: GMD, gray matter density; MDD, major depressive disorder. *p < 0.05, **p < 0.001
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subgroup. This might indicate these patients may be
more prone to affective instability given the right orbi-
tofrontal cortex is one of the key regions associated
emotional dysregulation with in depression [23].
There are several limitations in this study. Comprehen-
sive psychiatric evaluation for personality disorder was not
performed even though MDD patients with child abuse
may have comorbid personality disorders. Illness history
and characteristics of past and current major depressive
episodes including duration of MDD episode, age of onset
were not also assessed for the MDD patient group. A rela-
tively small number of MDD patients without abuse expe-
riences participated in this study. Medication history and
effect of medication was not fully assessed but this effect
is not so large since MRI scans were performed at baseline
and the very early stage of medication treatment for all
patients in this study.
The strength of this study was focusing on the additional
variable of childhood abuse in heterogeneous MDD pa-
tients. Until now, VBM studies of MDD patients have not
paid sufficient attention to accompanying early-life stress or
child abuse experiences. Child abuse and early-life stress
are important clinical factors in the comprehensive evalu-
ation of MDD patients and for planning prescription of
medication and psychotherapeutic approaches. Future neu-
roimaging studies investigating structural and functional
changes in patients with MDD should evaluate histories
about their early life. The orbitofrontal cortex may be a re-
gion significantly affected by physical or emotional abuse
during early life within the MDD patient group.
Conclusion
Using VBM we found abnormalities associated with
child abuse in the right orbitofrontal cortex and left
postcentral gyrus regions in a group of MDD patients.
This study also replicated previous findings that suggest
hypofrontality and limbic/subcortical hyperactivity in pa-
tients with MDD. To understand the complex patho-
genic mechanism associated with MDD in the brain,
further neuroimaging studies with a large number of
subjects and sophisticated design should be pursued.
Additional file
Additional file 1: Comparison of GMD in regions showing significant
difference between MDD with abuse subgroup and without abuse
subgroup. (DOCX 15 kb)
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